Copy number alterations of DNA mismatch repair (MMR) genes as novel prognostic markers in localised prostate cancer (CaP).

Authors

Melvin Chua

Melvin Chua

Radiation Medicine Program, Princess Margaret Hospital, Toronto, Canada, Toronto, ON, Canada

Melvin Chua , Emilie Lalonde , Osman Mahamud , Alejandro Berlin , Alan Dal Pra , Michèle Orain , Valerie Picard , Helene Hovington , Alain Bergeron , Yves Fradet , Bernard Têtu , Alice Meng , Junyan Zhang , Gaetano Zafarana , Julie Livingstone , Melania Pintilie , Theodorus van der Kwast , Michael Fraser , Paul Boutros , Robert G. Bristow

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer,Prostate Cancer

Sub Track

Prostate Cancer - Localized Disease

Citation

J Clin Oncol 34, 2016 (suppl 2S; abstr 96)

DOI

10.1200/jco.2016.34.2_suppl.96

Abstract #

96

Poster Bd #

E12

Abstract Disclosures

Similar Posters

First Author: Anna Couvillon

Poster

2023 ASCO Genitourinary Cancers Symposium

PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.

PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.

First Author: Channing Judith Paller

Poster

2023 ASCO Genitourinary Cancers Symposium

Clinical and genomic factors associated with tumor mutational burden (TMB) in prostate cancer.

Clinical and genomic factors associated with tumor mutational burden (TMB) in prostate cancer.

First Author: Helen Y Hougen

Poster

2022 ASCO Genitourinary Cancers Symposium

PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.

PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.

First Author: Channing Judith Paller